Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Am J Obstet Gynecol

Retrieve available abstracts of 131 articles:
HTML format



Single Articles


    July 2021
  1. DE WIT AE, DE Vries YA, DE Boer MK, Scheper C, et al
    Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials.
    Am J Obstet Gynecol. 2021 Jul 2. pii: S0002-9378(21)00774.
    PubMed     Abstract available


  2. RODRIGUEZ MI, Skye M, Edelman AB, Anderson L, et al
    Association of pharmacist prescription and 12 month contraceptive continuation rates.
    Am J Obstet Gynecol. 2021 Jul 1. pii: S0002-9378(21)00773.
    PubMed     Abstract available


    June 2021
  3. HARITON E, Shirazi TN, Douglas NC, Hershlag A, et al
    Anti-Mullerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals.
    Am J Obstet Gynecol. 2021 Jun 11. pii: S0002-9378(21)00685.
    PubMed     Abstract available


    April 2021
  4. KAIMAL A, Norton ME
    Society for Maternal-Fetal Medicine Consult Series #55: Counseling women at increased risk of maternal morbidity and mortality.
    Am J Obstet Gynecol. 2021;224:B16-B23.
    PubMed     Abstract available


    March 2021
  5. MILLS K, Marchand G, Sainz K, Azadi A, et al
    Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis.
    Am J Obstet Gynecol. 2021;224:258-265.
    PubMed     Abstract available


    January 2021
  6. SCHRIJVER LH, Antoniou AC, Olsson H, Mooij TM, et al
    Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    Am J Obstet Gynecol. 2021 Jan 22. pii: S0002-9378(21)00038.
    PubMed     Abstract available


    December 2020
  7. MERZ AA, Gutierrez-Sacristan A, Bartz D, Williams NE, et al
    Population attitudes toward contraceptive methods over time on a social media platform.
    Am J Obstet Gynecol. 2020 Dec 9. pii: S0002-9378(20)31378.
    PubMed     Abstract available


  8. RUSSELL CB, Evans ML, Qasba N, Frankel A, et al
    Medicaid sterilization consent forms: variation in rejection and payment consequences.
    Am J Obstet Gynecol. 2020;223:934-936.
    PubMed    


    November 2020
  9. GO VAA, Thomas MC, Singh B, Prenatt S, et al
    A systematic review of the psychosocial impact of fibroids before and after treatment.
    Am J Obstet Gynecol. 2020;223:674-708.
    PubMed     Abstract available


    October 2020
  10. JOULAUD P, Pithois A, Ramanah R
    VAGINAL BLEEDING FROM AN UNIDENTIFIED SUSPICIOUS UTERINE TUMOR IN A YOUNG WOMAN.
    Am J Obstet Gynecol. 2020 Oct 13. pii: S0002-9378(20)31185.
    PubMed    


  11. SCHULTHEIS P, Natalie Montoya M, Zhao Q, Archer J, et al
    Contraception and Ectopic Pregnancy Risk: A Prospective Observational Analysis.
    Am J Obstet Gynecol. 2020 Oct 10. pii: S0002-9378(20)31187.
    PubMed     Abstract available


  12. CHUNG YS, Woo HY, Lee JY, Park E, et al
    Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
    Am J Obstet Gynecol. 2020 Oct 8. pii: S0002-9378(20)31175.
    PubMed     Abstract available


    September 2020
  13. MONIZ MH, Peahl AF, Fendrick AM, Kolenic GE, et al
    Cost-Sharing, Postpartum Contraceptive Use, and Short Interpregnancy Interval Rates Among Commercially Insured Women.
    Am J Obstet Gynecol. 2020 Sep 5. pii: S0002-9378(20)30991.
    PubMed     Abstract available


  14. BEDFORD L, Parker SE, Davis E, Salzman E, et al
    Characteristics of the vaginal microbiome in women with and without clinically confirmed vulvodynia.
    Am J Obstet Gynecol. 2020;223:406.
    PubMed     Abstract available


  15. SONG X, Wu J, Zhou Y, Feng L, et al
    Reproductive and hormonal factors and risk of cognitive impairment among Singapore Chinese women.
    Am J Obstet Gynecol. 2020;223:410.
    PubMed     Abstract available


    August 2020
  16. WESTIN SN, Fellman B, Sun CC, Broaddus RR, et al
    Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.
    Am J Obstet Gynecol. 2020 Aug 14. pii: S0002-9378(20)30861.
    PubMed     Abstract available


  17. BEELEN P, VAN DEN Brink MJ, Herman MC, Geomini PM, et al
    Levonorgestrel releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
    Am J Obstet Gynecol. 2020 Aug 11. pii: S0002-9378(20)30844.
    PubMed     Abstract available


  18. TAUB RL, Ellis SA, Neal-Perry G, Magaret AS, et al
    The effect of testosterone on ovulatory function in transmasculine individuals.
    Am J Obstet Gynecol. 2020;223:229.
    PubMed     Abstract available


    June 2020
  19. CREININ MD
    Contraception across the transmasculine spectrum.
    Am J Obstet Gynecol. 2020 Jun 23. pii: S0002-9378(20)30660.
    PubMed    


  20. KREMPASKY C, Grimstad F
    Research is needed to assess breakthrough bleeding rates in transmasculine individuals utilizing hormonal contraception.
    Am J Obstet Gynecol. 2020 Jun 23. pii: S0002-9378(20)30661.
    PubMed    


  21. H ST, K GF, Anna B, Mika G, et al
    Long-Acting Reversible Contraception Free-of-Charge: Two-year Discontinuation, its Risk Factors and Reasons.
    Am J Obstet Gynecol. 2020 Jun 17. pii: S0002-9378(20)30641.
    PubMed     Abstract available


  22. COHEN MA, Powell AM, Coleman JS, Keller JM, et al
    Special Ambulatory Gynecologic Considerations in the Era of COVID-19 and Implications for Future Practice.
    Am J Obstet Gynecol. 2020 Jun 6. pii: S0002-9378(20)30621.
    PubMed     Abstract available


    May 2020
  23. ROBINSON EF, Moulder JK, Zerden ML, Miller AM, et al
    Call to Action: Preserving and Advocating for Essential Care for Women during the COVID-19 Pandemic.
    Am J Obstet Gynecol. 2020 May 13. pii: S0002-9378(20)30548.
    PubMed     Abstract available


  24. GUO XM, Hall EF, Mazzullo L, Djordjevic M, et al
    A low-cost approach to salpingectomy at cesarean delivery.
    Am J Obstet Gynecol. 2020;222:503.
    PubMed     Abstract available


    April 2020
  25. SONALKAR S, Koelper N, Creinin MD, Atrio JM, et al
    Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of success from a randomized trial.
    Am J Obstet Gynecol. 2020 Apr 16. pii: S0002-9378(20)30431.
    PubMed     Abstract available


  26. FOSTER DG
    The problems with a poverty argument for long-acting reversible contraceptive promotion.
    Am J Obstet Gynecol. 2020;222.
    PubMed    


  27. BLACKWELL S, Louis JM, Norton ME, Lappen JR, et al
    Reproductive services for women at high risk for maternal mortality: a report of the workshop of the Society for Maternal-Fetal Medicine, the American College of Obstetricians and Gynecologists, the Fellowship in Family Planning, and the Society of Fa
    Am J Obstet Gynecol. 2020;222:B2-B18.
    PubMed    


  28. LINDO JM
    Weighing the evidence on the likely effects of expanding access to LARCs on poverty.
    Am J Obstet Gynecol. 2020;222.
    PubMed    


  29. BROWN JA, Greenfield LT, Rapkin RB
    Special report: implementing immediate postpartum LARC in Florida.
    Am J Obstet Gynecol. 2020;222.
    PubMed     Abstract available


  30. MAPLES JM, Espey E, Evans ML, Breeze JL, et al
    Obstetrics-gynecology resident long-acting reversible contraception training: the role of resident and program characteristics.
    Am J Obstet Gynecol. 2020;222.
    PubMed     Abstract available


  31. HORVATH S, Bumpus M, Luchowski A
    From uptake to access: a decade of learning from the ACOG LARC program.
    Am J Obstet Gynecol. 2020;222.
    PubMed     Abstract available


    March 2020
  32. QUINN DA, Sileanu FE, Zhao X, Mor MK, et al
    History of unintended pregnancy and patterns of contraceptive use among racial and ethnic minority women Veterans.
    Am J Obstet Gynecol. 2020 Mar 3. pii: S0002-9378(20)30233.
    PubMed     Abstract available


    February 2020
  33. GOYAL V, McLoughlin Brooks IH, Wallace R, Dermish AI, et al
    Medication Abortion Use among Low-income and Rural Texans Before and During State-Imposed Restrictions and After FDA-updated Labeling.
    Am J Obstet Gynecol. 2020 Feb 25. pii: S0002-9378(20)30216.
    PubMed     Abstract available


  34. PETERS A, Siripong N, Wang L, Donnellan NM, et al
    Enhanced Recovery After Surgery Outcomes in Minimally Invasive Non-Hysterectomy Gynecologic Procedures.
    Am J Obstet Gynecol. 2020 Feb 19. pii: S0002-9378(20)30146.
    PubMed     Abstract available


  35. ROBERTS TA, Smalley JM, Baker LL, Weir LF, et al
    Influence of military contraceptive policy changes on contraception use and childbirth rates among new recruits.
    Am J Obstet Gynecol. 2020 Feb 7. pii: S0002-9378(20)30135.
    PubMed     Abstract available


    January 2020
  36. ALIGNE CA, Phelps R, Cranch JL, Korones SA, et al
    Impact of the Rochester LARC Initiative on Adolescents' Utilization of Long-Acting Reversible Contraception.
    Am J Obstet Gynecol. 2020 Jan 21. pii: S0002-9378(20)30037.
    PubMed     Abstract available


  37. PALM HC, Degnan J, Biefeld SD, Reese AL, et al
    An initiative to implement immediate postpartum long-acting reversible contraception in rural New Mexico.
    Am J Obstet Gynecol. 2020 Jan 21. pii: S0002-9378(20)30035.
    PubMed     Abstract available


  38. MANDELBAUM RS, Ciccone MA, Nusbaum DJ, Khoshchehreh M, et al
    Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device versus systemic therapy.
    Am J Obstet Gynecol. 2020 Jan 21. pii: S0002-9378(20)30028.
    PubMed     Abstract available


  39. MILLER R, Timor IE, Gyamfi-Bannerman C
    Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean scar pregnancy.
    Am J Obstet Gynecol. 2020 Jan 20. pii: S0002-9378(20)30038.
    PubMed     Abstract available


  40. TI AJ, Roe AH, Whitehouse KC, Smith RA, et al
    Effectiveness and Safety of Extending Intrauterine Device Duration: A Systematic Review.
    Am J Obstet Gynecol. 2020 Jan 15. pii: S0002-9378(20)30021.
    PubMed     Abstract available


  41. LI JL, Kilembe W, Inambao M, Vwalika B, et al
    FERTILITY INTENTIONS AND LONG-ACTING REVERSIBLE CONTRACEPTIVE USE AMONG HIV-NEGATIVE SINGLE MOTHERS IN ZAMBIA: Fertility intent and LARC use in Zambia.
    Am J Obstet Gynecol. 2020 Jan 14. pii: S0002-9378(20)30012.
    PubMed     Abstract available


  42. MALAMA K, Kilembe W, Inambao M, Hoagland A, et al
    A couple-focused, integrated unplanned pregnancy and HIV prevention program in urban and rural Zambia.
    Am J Obstet Gynecol. 2020 Jan 13. pii: S0002-9378(20)30010.
    PubMed     Abstract available


  43. CASTANO PM, Westhoff CL
    Experience with same-day placement of the 52mg levonorgestrel-releasing intrauterine system.
    Am J Obstet Gynecol. 2020 Jan 13. pii: S0002-9378(20)30009.
    PubMed     Abstract available


    December 2019
  44. CHANCE K, Miles H, Frances G
    Contraceptive counseling should be offered to all patients initiating testosterone as gender-affirming hormone therapy.
    Am J Obstet Gynecol. 2019 Dec 20. pii: S0002-9378(19)32772.
    PubMed    


  45. RODRIGUEZ MI, Dissanayake M, Swartz JJ, Funkhouser S, et al
    Immediate postpartum long acting, reversible contraceptive use among the Emergency Medicaid population: continuation rates and satisfaction.
    Am J Obstet Gynecol. 2019 Dec 20. pii: S0002-9378(19)32773.
    PubMed    


  46. SCHUBERT FD, Carey JM
    Data unclear on pregnancy risk in transmasculine individuals on testosterone.
    Am J Obstet Gynecol. 2019 Dec 20. pii: S0002-9378(19)32771.
    PubMed     Abstract available


  47. CHEN BA, Eisenberg DL, Schreiber CA, Turok DK, et al
    Bleeding changes after levonorgestrel 52mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding.
    Am J Obstet Gynecol. 2019 Dec 19. pii: S0002-9378(19)32764.
    PubMed     Abstract available


  48. LIBERTY A, Yee K, Darney BG, Lopez-Defede A, et al
    Coverage of immediate postpartum long acting reversible contraception has improved birth intervals for at risk populations.
    Am J Obstet Gynecol. 2019 Dec 14. pii: S0002-9378(19)32703.
    PubMed     Abstract available


  49. PAUL R, Huysman BC, Maddipati R, Madden T, et al
    Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
    Am J Obstet Gynecol. 2019 Dec 12. pii: S0002-9378(19)32687.
    PubMed     Abstract available


  50. LACY MM, Mcmurtry Baird S, Scott TA, Barker B, et al
    Statewide Quality Improvement Initiative to Implement Immediate Postpartum Long-Acting Reversible Contraception.
    Am J Obstet Gynecol. 2019 Dec 12. pii: S0002-9378(19)32693.
    PubMed     Abstract available


  51. MUKAMUYANGO J, Ingabire R, Parker R, Nyombayire J, et al
    Motivational interviewing to promote long acting reversible contraception among Rwandan couples wishing to prevent or delay pregnancy.
    Am J Obstet Gynecol. 2019 Dec 12. pii: S0002-9378(19)32701.
    PubMed     Abstract available


  52. MAZZA D, Watson CJ, Taft A, Lucke J, et al
    Increasing long acting reversible contraceptives: The Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial.
    Am J Obstet Gynecol. 2019 Dec 11. pii: S0002-9378(19)32688.
    PubMed     Abstract available


  53. GAWRON LM, Gero A, Kushner KL, Turok DK, et al
    Unprotected intercourse in the 2 weeks prior to "quick start" initiation of an etonogestrel contraceptive implant with and without use of oral emergency contraception.
    Am J Obstet Gynecol. 2019 Dec 3. pii: S0002-9378(19)32702.
    PubMed    


  54. HOLT K, Reed R, Perry JC, Scott C, et al
    Beyond same-day LARC access: A person-centered framework for advancing high quality, equitable contraceptive care.
    Am J Obstet Gynecol. 2019 Dec 3. pii: S0002-9378(19)32700.
    PubMed     Abstract available


  55. GUIAHI M
    Religious refusals to long-acting reversible contraceptives in Catholic settings: a call for evidence.
    Am J Obstet Gynecol. 2019 Dec 2. pii: S0002-9378(19)32691.
    PubMed     Abstract available


    November 2019
  56. BRANDI K, Fuentes L
    The History of Tiered-Effectiveness Contraceptive Counseling and its Effects on Patient-Centered Family Planning Care.
    Am J Obstet Gynecol. 2019 Nov 30. pii: S0002-9378(19)32692.
    PubMed     Abstract available


  57. HARPER MKD, Loper MAC, Louison MLM, Morse JE, et al
    Stage-based implementation of Immediate Postpartum Long Acting Reversible Contraception Using a Reproductive Justice Framework.
    Am J Obstet Gynecol. 2019 Nov 30. pii: S0002-9378(19)32694.
    PubMed     Abstract available


  58. BATTARBEE AN, Sinkey RG, Harper LM, Oparil S, et al
    Chronic Hypertension in Pregnancy.
    Am J Obstet Gynecol. 2019 Nov 9. pii: S0002-9378(19)32613.
    PubMed     Abstract available


  59. SCHMIDT-HANSEN M, Cameron S, Lohr PA, Hasler E, et al
    Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: A systematic review with meta-analyses.
    Am J Obstet Gynecol. 2019 Nov 9. pii: S0002-9378(19)32615.
    PubMed     Abstract available


    September 2019
  60. RICE LW, Espey E, Fenner D, Gregory KD, et al
    UNIVERSAL ACCESS TO CONTRACEPTION: WOMEN, FAMILIES, AND COMMUNITIES BENEFIT.
    Am J Obstet Gynecol. 2019 Sep 19. pii: S0002-9378(19)31121.
    PubMed     Abstract available


  61. DE NADAI MN, Poli-Neto OB, Franceschini SA, Yamaguti EM, et al
    Intracervical block for levonorgestrel-releasing intrauterine system placement among nulligravid women: a randomized double-blind controlled trial.
    Am J Obstet Gynecol. 2019 Sep 18. pii: S0002-9378(19)31120.
    PubMed     Abstract available


    August 2019
  62. KREMPASKY C, Harris M, Abern L, Grimstad F, et al
    Contraception Across the Transmasculine Spectrum.
    Am J Obstet Gynecol. 2019 Aug 5. pii: S0002-9378(19)30955.
    PubMed     Abstract available


    May 2019
  63. DASHRAATH P, Kailun C, Li M
    Umbilical endometriosis (Villar's nodule).
    Am J Obstet Gynecol. 2019 May 2. pii: S0002-9378(19)30617.
    PubMed    


    April 2019
  64. GOLDIN EVANS M, Broyles S, Frederiksen B, Gee RE, et al
    Long-Acting Reversible Contraceptive (LARC) Utilization After Policy Change Increasing Device Reimbursement to Wholesale Acquisition Cost in Louisiana.
    Am J Obstet Gynecol. 2019 Apr 28. pii: S0002-9378(19)30589.
    PubMed     Abstract available


    March 2019
  65. ODUYEBO T, Zapata LB, Boutot ME, Tepper NK, et al
    Factors Associated with Postpartum Use of Long-Acting Reversible Contraception.
    Am J Obstet Gynecol. 2019 Mar 15. pii: S0002-9378(19)30480.
    PubMed     Abstract available


    February 2019
  66. AS-SANIE S, Black R, Giudice LC, Gray Valbrun T, et al
    Assessing Research Gaps and Unmet Needs in Endometriosis.
    Am J Obstet Gynecol. 2019 Feb 18. pii: S0002-9378(19)30385.
    PubMed     Abstract available


  67. DEHLENDORF C, Fitzpatrick J, Fox E, Holt K, et al
    Cluster Randomized Trial of a Patient-Centered Contraceptive Decision Support Tool, My Birth Control.
    Am J Obstet Gynecol. 2019 Feb 11. pii: S0002-9378(19)30356.
    PubMed     Abstract available


  68. MEAIDI A, Friedrich S, Alexander Gerds T, Lidegaard O, et al
    Risk factors for surgical intervention of early medical abortion.
    Am J Obstet Gynecol. 2019 Feb 11. pii: S0002-9378(19)30355.
    PubMed     Abstract available


  69. MAHLA RS
    The Unforeseen Psychological, Behavioral and Physiological Complications Associated with Intra Uterine Device use Contraceptions.
    Am J Obstet Gynecol. 2019 Feb 8. pii: S0002-9378(19)30347.
    PubMed    


  70. KEBODEAUX CA, Schwartz BI
    Reply to Reply to: The Unforeseen Psychological, Behavioral and Physiological Complications Associated with Intra Uterine Device use Contraceptions.
    Am J Obstet Gynecol. 2019 Feb 8. pii: S0002-9378(19)30344.
    PubMed    


  71. VRICELLA LK, Gawron LM, Louis JM
    Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high-risk for medical complications.
    Am J Obstet Gynecol. 2019 Feb 7. pii: S0002-9378(19)30352.
    PubMed     Abstract available


    January 2019
  72. VENKATESH KK, Clark LH, Stamilio DM
    Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Am J Obstet Gynecol. 2019;220:106.
    PubMed     Abstract available


    December 2018
  73. SIMMONS RG, Sanders JN, Geist C, Gawron L, et al
    Predictors of contraceptive switching and discontinuation within the first six months of use among HER Salt Lake study participants.
    Am J Obstet Gynecol. 2018 Dec 18. pii: S0002-9378(18)32232.
    PubMed     Abstract available


  74. SERGISON JE, Maldonado LY, Gao X, Hubacher D, et al
    Levonorgestrel Intrauterine System associated amenorrhea: a systematic review and meta-analysis.
    Am J Obstet Gynecol. 2018 Dec 7. pii: S0002-9378(18)32216.
    PubMed     Abstract available


    November 2018
  75. CONTI JA, Lerma K, Schneyer R, Hastings CV, et al
    Self-Administered Vaginal Lidocaine Gel for Pain Management with Intrauterine Device Insertion: A Blinded, Randomized Controlled Trial.
    Am J Obstet Gynecol. 2018 Nov 13. pii: S0002-9378(18)32107.
    PubMed     Abstract available


    October 2018
  76. MORGAN DM, Kamdar NS, Dalton VK, Swenson CW, et al
    Savings with Expanding Use of the Levonorgestrel IUD and Fewer Benign Hysterectomies.
    Am J Obstet Gynecol. 2018 Oct 12. pii: S0002-9378(18)30897.
    PubMed    


    September 2018
  77. MADDEN T, Barker AR, Huntzberry K, Secura GM, et al
    Medicaid Savings from the Contraceptive CHOICE Project: a Cost Savings Analysis.
    Am J Obstet Gynecol. 2018 Sep 4. pii: S0002-9378(18)30722.
    PubMed     Abstract available


    July 2018
  78. FIASCONE S, Danilack VA, Kao MJ, Cohen M, et al
    While Women Await Surgery for Type I Endometrial Cancer, Depot Medroxyprogesterone Acetate Reduces Tumor Glandular Cellularity.
    Am J Obstet Gynecol. 2018 Jul 28. pii: S0002-9378(18)30611.
    PubMed     Abstract available


  79. GOLDTHWAITE LM, Cahill EP, Voedisch AJ, Blumenthal PD, et al
    Postpartum intrauterine devices: Clinical and programmatic review.
    Am J Obstet Gynecol. 2018 Jul 19. pii: S0002-9378(18)30582.
    PubMed     Abstract available


    June 2018
  80. GURNEY EP, Sonalkar S, Mcallister A, Sammel MD, et al
    Six-month expulsion of postplacental copper intrauterine devices placed after vaginal delivery.
    Am J Obstet Gynecol. 2018 Jun 2. pii: S0002-9378(18)30442.
    PubMed     Abstract available


    May 2018
  81. HANLEY GE, Kwon JS, Finlayson SJ, Huntsman DG, et al
    Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: A cohort study from British Columbia, Canada.
    Am J Obstet Gynecol. 2018 May 28. pii: S0002-9378(18)30429.
    PubMed     Abstract available


  82. WESTHOFF CL, Pike MC
    Hormonal contraception and breast cancer.
    Am J Obstet Gynecol. 2018 May 17. pii: S0002-9378(18)30247.
    PubMed     Abstract available


  83. DALTON VK, Carlos RC, Kolenic GE, Moniz MH, et al
    The impact of cost sharing on women's use of annual examinations and effective contraception.
    Am J Obstet Gynecol. 2018 May 9. pii: S0002-9378(18)30382.
    PubMed     Abstract available


    April 2018
  84. MENGESHA BM, Carter JT, Dehlendorf CE, Rodriguez AJ, et al
    Perioperative pregnancy interval, contraceptive counseling experiences and contraceptive use in women undergoing bariatric surgery.
    Am J Obstet Gynecol. 2018 Apr 7. pii: S0002-9378(18)30286.
    PubMed     Abstract available


    March 2018
  85. THOMPSON KMJ, Rocca CH, Stern L, Morfesis J, et al
    Training contraceptive providers to offer intrauterine devices and implants in contraceptive care: a cluster randomized trial.
    Am J Obstet Gynecol. 2018 Mar 22. pii: S0002-9378(18)30222.
    PubMed     Abstract available


  86. OKOROH EM, Kane DJ, Gee RE, Kieltyka L, et al
    Policy Change is Not Enough: Engaging Provider Champions on Immediate Postpartum Contraception.
    Am J Obstet Gynecol. 2018 Mar 9. pii: S0002-9378(18)30213.
    PubMed     Abstract available


  87. DANIEL S, Rotem R, Koren G, Lunenfeld E, et al
    Vaginal anti-mycotics and the risk for spontaneous abortions.
    Am J Obstet Gynecol. 2018 Mar 3. pii: S0002-9378(18)30172.
    PubMed     Abstract available


  88. ACHILLES SL, Austin MN, Meyn LA, Mhlanga F, et al
    Impact of contraceptive initiation on vaginal microbiota.
    Am J Obstet Gynecol. 2018 Mar 2. pii: S0002-9378(18)30176.
    PubMed     Abstract available


    February 2018
  89. GOMEZ AM, McCullough C, Hoff C
    Expectations of Future Provision of Pharmacist-Prescribed Hormonal Contraception in California.
    Am J Obstet Gynecol. 2018 Feb 20. pii: S0002-9378(18)30149.
    PubMed    


    January 2018
  90. BELLOWS BK, Tak CR, Sanders JN, Turok DK, et al
    Cost-effectiveness of emergency contraception options over one year.
    Am J Obstet Gynecol. 2018 Jan 31. pii: S0002-9378(18)30074.
    PubMed     Abstract available


    December 2017
  91. SINGH SS, Belland L, Leyland N, von Riedemann S, et al
    The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids.
    Am J Obstet Gynecol. 2017 Dec 21. pii: S0002-9378(17)32697.
    PubMed     Abstract available


  92. OLIVEIRA CR, Rock RM, Shapiro ED, Xu X, et al
    Missed Opportunities for HPV Immunization Among Young Adult Women.
    Am J Obstet Gynecol. 2017 Dec 6. pii: S0002-9378(17)32473.
    PubMed     Abstract available


    November 2017
  93. ROSER BJ, Rubin SE, Nagarajan N, Wieland DL, et al
    A Data Extraction Algorithm for Assessment of Contraceptive Counseling and Provision.
    Am J Obstet Gynecol. 2017 Nov 23. pii: S0002-9378(17)32345.
    PubMed     Abstract available


  94. NIPPITA S, Haviland MJ, Voit SF, Perez-Peralta J, et al
    Randomized trial of high- and low-fidelity simulation to teach intrauterine contraception placement.
    Am J Obstet Gynecol. 2017 Nov 11. pii: S0002-9378(17)32318.
    PubMed     Abstract available


    October 2017
  95. JUDGE CP, Zhao X, Sileanu FE, Mor MK, et al
    Medical contraindications to estrogen and contraceptive use among women Veterans.
    Am J Obstet Gynecol. 2017 Oct 27. pii: S0002-9378(17)31213.
    PubMed     Abstract available


  96. DINA B, Peipert L, Zhao Q, Peipert JF, et al
    Anticipated Pain as a Predictor of Discomfort with Intrauterine Device Placement.
    Am J Obstet Gynecol. 2017 Oct 24. pii: S0002-9378(17)31209.
    PubMed     Abstract available


  97. NEZHAT C, Li A, Falik R, Copeland D, et al
    Bowel Endometriosis: Diagnosis and Management.
    Am J Obstet Gynecol. 2017 Oct 12. pii: S0002-9378(17)31180.
    PubMed     Abstract available


  98. ROCCA CH, Goodman S, Grossman DJ, Cadwallader K, et al
    Contraception after medication abortion in the United States: Results from a cluster randomized trial.
    Am J Obstet Gynecol. 2017 Oct 3. pii: S0002-9378(17)31135.
    PubMed     Abstract available


    September 2017
  99. MCNICHOLAS CP, Klugman JB, Zhao Q, Peipert JF, et al
    Condom Use and Incident Sexually Transmitted Infection after Initiation of Long-Acting Reversible Contraception.
    Am J Obstet Gynecol. 2017 Sep 14. pii: S0002-9378(17)31115.
    PubMed     Abstract available


  100. OLADOSU FA, Tu FF, Hellman KM
    NSAID resistance in dysmenorrhea: epidemiology, causes, and treatment.
    Am J Obstet Gynecol. 2017 Sep 6. pii: S0002-9378(17)31095.
    PubMed     Abstract available


    August 2017
  101. HADDAD LB, Monsour M, Tepper NK, Whiteman MK, et al
    Trends in Contraceptive Use According to HIV status Among Privately-Insured Women in the United States.
    Am J Obstet Gynecol. 2017 Aug 30. pii: S0002-9378(17)30941.
    PubMed     Abstract available


  102. TUROK DK, Leeman L, Sanders JN, Thaxton L, et al
    Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial.
    Am J Obstet Gynecol. 2017 Aug 23. pii: S0002-9378(17)30938.
    PubMed     Abstract available


  103. QIU H, Yuan Z
    Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study.
    Am J Obstet Gynecol. 2017 Aug 23. pii: S0002-9378(17)30948.
    PubMed    


  104. GOLDTHWAITE LM, Sheeder J, Hyer J, Tocce K, et al
    Postplacental intrauterine device expulsion by 12 weeks: A prospective cohort study.
    Am J Obstet Gynecol. 2017 Aug 18. pii: S0002-9378(17)30935.
    PubMed     Abstract available


    July 2017
  105. SPENCER JC, Louie M, Moulder JK, Ellis V, et al
    Cost effectiveness of treatments for heavy menstrual bleeding.
    Am J Obstet Gynecol. 2017 Jul 25. pii: S0002-9378(17)30868.
    PubMed     Abstract available


  106. SIMMONS KB, Haddad LB, Nanda K, Curtis KM, et al
    Drug interactions between non-rifamycin antibiotics and hormonal contraception: A systematic review.
    Am J Obstet Gynecol. 2017 Jul 7. pii: S0002-9378(17)30845.
    PubMed     Abstract available


    June 2017
  107. STEVENS J, Lutz R, Osuagwu N, Rotz D, et al
    A Randomized Trial of Motivational Interviewing and Facilitated Contraceptive Access to Prevent Rapid Repeat Pregnancy among Adolescent Mothers.
    Am J Obstet Gynecol. 2017 Jun 12. pii: S0002-9378(17)30746.
    PubMed     Abstract available


  108. AVERBACH S, Kakaire O, Kayiga H, Lester F, et al
    Immediate versus delayed postpartum use of levonorgestrel contraceptive implants: a randomized controlled trial in Uganda.
    Am J Obstet Gynecol. 2017 Jun 10. pii: S0002-9378(17)30741.
    PubMed     Abstract available


    May 2017
  109. GRANT ECG
    Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy.
    Am J Obstet Gynecol. 2017 May 11. pii: S0002-9378(17)30610.
    PubMed    


  110. IVERSEN L, Hannaford PC, Fielding S
    Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study - Authors reply (ref L17-040AR1).
    Am J Obstet Gynecol. 2017 May 11. pii: S0002-9378(17)30611.
    PubMed    


    April 2017
  111. MARAVILLA JC, Betts KS, Couto E Cruz C, Alati R, et al
    Factors influencing repeated teenage pregnancy: a review and meta-analysis.
    Am J Obstet Gynecol. 2017 Apr 19. pii: S0002-9378(17)30522.
    PubMed     Abstract available


    March 2017
  112. JUDGE CP, Borrero S
    Contraceptive decision making after the 2016 United States Presidential Election.
    Am J Obstet Gynecol. 2017 Mar 30. pii: S0002-9378(17)30463.
    PubMed    


  113. EGGEBROTEN JL, Sanders JN, Turok DK
    Immediate postpartum intrauterine device and implant program outcomes: A prospective analysis.
    Am J Obstet Gynecol. 2017 Mar 22. pii: S0002-9378(17)30426.
    PubMed     Abstract available


  114. PHILLIPS SJ, Hofler LG, Modest AM, Harvey LF, et al
    Continuation of copper and levonorgestrel intrauterine devices: A retrospective cohort study.
    Am J Obstet Gynecol. 2017 Mar 15. pii: S0002-9378(17)30416.
    PubMed     Abstract available


  115. NELSON AL, Kaunitz AM
    Long-Acting Reversible Contraception: An Important Solution to Reduce Unintended Pregnancy.
    Am J Obstet Gynecol. 2017 Mar 8. pii: S0002-9378(17)30415.
    PubMed     Abstract available


  116. BOCANEGRA HT, Braughton M, Bradsberry M, Howell M, et al
    Racial and ethnic disparities in postpartum care and contraception in California's Medicaid program.
    Am J Obstet Gynecol. 2017 Mar 3. pii: S0002-9378(17)30368.
    PubMed     Abstract available


    February 2017
  117. BRUNSON MR, Klein DA, Olsen CH, Weir L, et al
    Postpartum Contraception: Initiation and Effectiveness in a Large Universal Healthcare System.
    Am J Obstet Gynecol. 2017 Feb 28. pii: S0002-9378(17)30362.
    PubMed     Abstract available


  118. CHEN YJ, Hsu TF, Huang BS, Tsai HW, et al
    Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence A randomized controlled study.
    Am J Obstet Gynecol. 2017 Feb 13. pii: S0002-9378(17)30248.
    PubMed     Abstract available


  119. SANDERS JN, Turok DK, Gawron LM, Law A, et al
    Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: A retrospective review.
    Am J Obstet Gynecol. 2017 Feb 8. pii: S0002-9378(17)30180.
    PubMed     Abstract available


  120. IVERSEN L, Sivasubramaniam S, Lee AJ, Fielding S, et al
    Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
    Am J Obstet Gynecol. 2017 Feb 8. pii: S0002-9378(17)30179.
    PubMed     Abstract available


  121. CALLEGARI LS, Aiken AR, Dehlendorf C, Cason P, et al
    Addressing potential pitfalls of reproductive life planning with patient-centered counseling.
    Am J Obstet Gynecol. 2017;216:129-134.
    PubMed     Abstract available


    January 2017
  122. MCNICHOLAS C, Swor E, Wan L, Peipert JF, et al
    Prolonged Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device - Two Years Beyond FDA-Approved Duration.
    Am J Obstet Gynecol. 2017 Jan 29. pii: S0002-9378(17)30171.
    PubMed     Abstract available


  123. CALLEGARI LS, Zhao X, Schwarz EB, Rosenfeld E, et al
    Racial/ethnic differences in contraceptive preferences, beliefs, and self-efficacy among women veterans.
    Am J Obstet Gynecol. 2017 Jan 4. pii: S0002-9378(16)46489.
    PubMed     Abstract available


    December 2016
  124. DIEDRICH JT, Klein DA, Peipert JF
    Long-Acting Reversible Contraception in Adolescents: A Systematic Review and Meta-Analysis.
    Am J Obstet Gynecol. 2016 Dec 27. pii: S0002-9378(16)46213.
    PubMed     Abstract available


  125. CHAMPALOUX SW, Tepper NK, Monsour M, Curtis KM, et al
    Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke.
    Am J Obstet Gynecol. 2016 Dec 26. pii: S0002-9378(16)46208.
    PubMed     Abstract available


  126. ZIGLER RE, Mcnicholas CP
    Unscheduled Vaginal Bleeding with Progestin-only Contraceptive Use.
    Am J Obstet Gynecol. 2016 Dec 14. pii: S0002-9378(16)33176.
    PubMed     Abstract available


  127. FRISSE AC, Marrazzo JM, Tutlam NT, Schreiber CA, et al
    Validity of self-reported history of Chlamydia trachomatis infection.
    Am J Obstet Gynecol. 2016 Dec 14. pii: S0002-9378(16)33173.
    PubMed     Abstract available


    October 2016
  128. KARPILOW QC, Thomas AT
    Reassessing the Importance of Long-Acting Contraception.
    Am J Obstet Gynecol. 2016 Oct 20. pii: S0002-9378(16)30907.
    PubMed     Abstract available


    September 2016
  129. HUBACHER D, Spector H, Monteith C, Chen PL, et al
    Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Am J Obstet Gynecol. 2016 Sep 1. pii: S0002-9378(16)30645.
    PubMed     Abstract available


    July 2016
  130. HAWKINS BRESSLER L, Bernardi LA, De Chavez PJ, Baird DD, et al
    Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women.
    Am J Obstet Gynecol. 2016 Jul 11. pii: S0002-9378(16)30446.
    PubMed     Abstract available


    May 2016
  131. TUROK DK, Eisenberg DL, Teal SB, Keder LM, et al
    A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.
    Am J Obstet Gynecol. 2016 May 12. pii: S0002-9378(16)30212.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: